Patient Rating:

No Rating Available?

Hassan M. Yaish, M.D.

Specialties

Languages

  • Arabic
  • English

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 662-4700 Primary Children's Hospital
Pediatric Hematology/Oncology
100 N Mario Capecchi Drive
Salt Lake City, UT 84113

Bio

Hassan M Yaish, MD.

Medical Director, Intermountain Hemophilia and Thrombosis Treatment Center.

Graduated from college of Medicine, University of Damascus in 1964

Internship in internal medicine and pediatrics at Augesta Victoria Hospital in Jerusalem and Damascus city Hospital in Damascus, Syria.

Residency in pediatrics at the Royal medical services at the base hospital in Amman, Jordan and William Beaumont Medical center in Royal Oak, Michigan

Hematology /Oncology fellowship at william Beaumont Medical center, Royal Oak , MI.

Clerkship at Fred Hutchinson cancer center, in Seattle, WA for bone marrow transplant in 1991.

Studies conducted during fellowship and early career in pediatric hematology were mostly on thrombocytopenia in children , neonatal hematology and bleeding disorders.

-Main interest therefore was in benign hematology such as: Anemia, Neutropenia and coagulation defects.

-Neonatal Hematological disorders , and hyperbilirubinemia.

-Bleeding disorders, inherited and acquired.

-Thrombosis and thrombophilia, diagnosis and management.

I gained some experience while working outside the united states in the diagnosis and manageconditions of conditions rarely seen in the USA.

- Red Blood Cell enzyme deficiency such as G6PD, clinical manifestations in various types and management.

-Hemoglobinopathy and Thalassemia.

- Lead poisoning .

Based on morphologic findings of blood smears in neonates and young infants, early diagnosis of red cell membrane defects , enzymopathies , and other hemolytic entities associated with hyperbilirubinemia can be identified in otherwise conditions which might have been labelled as "idiopathic"

-Hereditary Spherocytosis, Elliptocytosis, Pyropoikilocytosis.

-G6PD deficiency, Pyruvate kinase deficiency.

-Infantile pyknocytosis.

-Schistocytic hemolytic anemia.

Board Certification and Academic Information

Academic Departments Pediatrics - Professor (Clinical)
Academic Divisions Pediatric Hematology/Oncology
Board Certification American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Ped Hematology-Oncology)

Academic Profile

Board Certification and Academic Information

Academic Departments Pediatrics - Professor (Clinical)
Academic Divisions Pediatric Hematology/Oncology
Board Certification American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Ped Hematology-Oncology)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 662-4700 Primary Children's Hospital
Pediatric Hematology/Oncology
100 N Mario Capecchi Drive
Salt Lake City, UT 84113

Academic Bio

Hassan M Yaish, MD.

Graduated from college of Medicine, University of Damascus in 1964

Internship in internal medicine and pediatrics at Augesta Victoria Hospital in Jerusalem and Damascus city Hospital in Damascus, Syria.

Residency in pediatrics at the Royal medical services at the base hospital in Amman, Jordan and William Beaumont hospital in Royal Oak, Michigan

Hematology /Oncology fellowship at william Beaumont hospital, Royal Oak , MI.

Studies conducted during fellowship were mostly on thrombocytopenia in children resulting in an original publication in journal of pediatrics in 1975 confirming , for the first time , the efficacy of steroids therapy in children with ITP, contrary to what was believed by others at that time.

Intense training in blood cells morphology and technical procedures to assist in the diagnosis of blood disorders especially in the neonates and infants.

1984-1992 served as chairman of the department of pediatrics at a tertiary care medical center in Riyadh , Saudi Arabia ( King Fahad Hospital and medical center) where I established the first pediatric oncology department . I served as assistant then associate professor of pediatrics at King Saud university in Riyadh.

During that period, I encountered several clinical pictures in infants and young children ranging from slight anemia and learning disability to severe encephalopathy of unknown etiology which were later on proved to be related to lead poisoning . The clue was the basophilic stippling i noted on blood smear examination. I conducted some research and established a public campain to raise awareness for prevention and early identification of affected children.

I also started a program to screen newborns for Red Blood Cells abnormalities including hemoglobinopathies and enzymopathies. Several publications on the topics were published in local and international journals.

I served as division head of pediatric hematology at Henry Ford Hospital in Detroit ,MI from 1992 -2002. During that period I ran a service taking care of patients with lead poisoning , sickle cell disease and Thalassemia. I was mentoring and teaching students from university of Michigan as well as from Case western university, where I held an assistant professor title at the second.

2003 - Present. I joined the Primary children Medical Center, and the University of Utah as a pediatric hematologist oncologist.

I was initially appointed as associate professor before being promoted to professor. My main contribution to the program was the introduction of microscopic morphology as a major tool for diagnosing blood disorers rather that depending on extensive battery of costly tests to reach a diagnosis. Training many fellows and residents as well as medical students in morphology , has changed the culture in the institution . Morphology became a valuable tool in patient care and management.

I coordinate the monthly hematopathology tumor board meeting discussing the very unusual and morphologically challenging cases in the form of teaching session for large group of trainees and attendings.

During the last few years, many students, house officers and fellows became skilled in the field of morphology and were able to teach and instruct their juniors resulting in extending the life of the field of morphology, which many thought and feared that it will soon die away.

Several papers on morphologic diagnoses were published. Last year an application for a grant to help identifying the cause of extreme hyperbilirubinemia in neonates was submitted and a neonatal hematology clinic was established. It is hoped that many of the more than 50% idiopathic hyperbilirubinemia in neonates will not be idiopathic any more if one will be able to examine each blood smear of such babies.

I have participated in Several national research studies some are currently ongoing : The CDC study of inhibitors to clotting factors in patients with Hemophilia, the utilization of Thrombopoietin agonists for treatment of chronic refractory ITP, as well as trials for the efficacy and safety of new clotting factors in patients with hemophilia.

Education

Education History

Type School Degree
Clerkship Fred Hutchinson Cancer Research Center
Transplantation Surgery
Clinical Clerkship
Fellowship William Beaumont Hospital Medical Center
Pediatric Hematology/Oncology
Fellow
Residency William Beaumont Hospital Medical Center
Pediatrics
Resident
Residency Jordan Royal Medical Services
Pediatrics
Resident
Internship Jordan Royal Medical Services
Internal Medicine
Intern
Professional Medical Damascus University
Medicine
M.D.
Undergraduate University of Damascus, College of Science
Biology, Chemistry, and Physics
B.S.

Publications

Selected Provider Publications

Journal Article

  1. HM Yaish, RD Christensen, and A Agrawal (2013). A neonate with Coomb's -negative hemolytic jaundice with spherocytes but normal erythrocyte indices: a rare case of autosomal-recessive hereditary spherocytosis due to alpha-spectrin deficiency. J Perinatol, 33(2013), 404-406.
  2. RD Christensen and HM Yaish (2012). A neonate with Pelger-Huet anomaly,cleft lip and palate, and agenesis of the corpus callosum, with a chromosomal microdeletion involving 1q42.12. J Perinatol, 32, 238-40.
  3. Robert D Christensen, MD, Hassan M Yaish, MD, Charlotte BJohnson, MS, PNP-C, Paola Bianchi, PhD, and Alberto Zanella, MD (2011). Six Children With Pyruvate Kinase Deficiencyfrom One Small Town:Molecular Characterization of the PK-LR Gene. J Pediatr, 159, 695-7.

Abstract

  1. HYaish and GRodgers (2010). Alloantibodies in Type 3 Von Willebrand disease: report of Two Cases and Review Of The Literature [Abstract]. Haemophilia, 16(suppl.4), 156.

Clinical Trials

Clinical Trials

Video & News